# Johnson & Johnson quarterly revenue

entity: /record/johnson-johnson.md  
predicate: quarterly_revenue  
page: /record/johnson-johnson/quarterly_revenue  
as_of: 2026-11-09  
cite: AsOf. "Johnson & Johnson quarterly revenue: 25,399,000,000 United States dollar", as of 2026-09-27. Claim clm_0641FC210206, https://asof.is/claim/clm_0641FC210206, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.  

As of November 9, 2026, Johnson & Johnson's quarterly revenue on the AsOf record is $25.4 billion, dated September 27, 2026, from a primary source (sec.gov).

36 claims on Johnson & Johnson's quarterly revenue, 1 open and 35 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted.

## Current quarterly revenue

What the record asserts on 2026-11-09.

- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 25,399,000,000 United States dollar | valid 2026-09-27 to present | conf 0.95 | valid | [clm_0641FC210206](/claim/clm_0641FC210206.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm

## Every dated value

One claim per line, oldest first. Superseded claims stay visible.

- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 16,475,000,000 United States dollar | valid 2012-07-01 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_6F9C56DBC614](/claim/clm_6F9C56DBC614.md) | [clm_42EF4BA66681](/claim/clm_42EF4BA66681.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 17,052,000,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_6F97DEF4B601](/claim/clm_6F97DEF4B601.md) | [clm_6F9C56DBC614](/claim/clm_6F9C56DBC614.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 17,505,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_7487255D4F9B](/claim/clm_7487255D4F9B.md) | [clm_6F97DEF4B601](/claim/clm_6F97DEF4B601.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 17,877,000,000 United States dollar | valid 2013-06-30 to 2013-09-29 | conf 0.95 | superseded | superseded_by [clm_F4FECC157EBC](/claim/clm_F4FECC157EBC.md) | [clm_7487255D4F9B](/claim/clm_7487255D4F9B.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 17,575,000,000 United States dollar | valid 2013-09-29 to 2014-03-30 | conf 0.95 | superseded | superseded_by [clm_DA690338428C](/claim/clm_DA690338428C.md) | [clm_F4FECC157EBC](/claim/clm_F4FECC157EBC.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 18,115,000,000 United States dollar | valid 2014-03-30 to 2014-06-29 | conf 0.95 | superseded | superseded_by [clm_5CE1ED60A519](/claim/clm_5CE1ED60A519.md) | [clm_DA690338428C](/claim/clm_DA690338428C.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 19,495,000,000 United States dollar | valid 2014-06-29 to 2014-09-28 | conf 0.95 | superseded | superseded_by [clm_EEE18AA71A3F](/claim/clm_EEE18AA71A3F.md) | [clm_5CE1ED60A519](/claim/clm_5CE1ED60A519.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040614000089/0000200406-14-000089-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 18,467,000,000 United States dollar | valid 2014-09-28 to 2017-10-01 | conf 0.95 | superseded | superseded_by [clm_3D692F025919](/claim/clm_3D692F025919.md) | [clm_EEE18AA71A3F](/claim/clm_EEE18AA71A3F.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040614000097/0000200406-14-000097-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 19,650,000,000 United States dollar | valid 2017-10-01 to 2018-04-01 | conf 0.95 | superseded | superseded_by [clm_74645F257415](/claim/clm_74645F257415.md) | [clm_3D692F025919](/claim/clm_3D692F025919.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040618000055/0000200406-18-000055-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 20,009,000,000 United States dollar | valid 2018-04-01 to 2018-07-01 | conf 0.95 | superseded | superseded_by [clm_B831D08FB7D2](/claim/clm_B831D08FB7D2.md) | [clm_74645F257415](/claim/clm_74645F257415.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040619000033/0000200406-19-000033-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 20,830,000,000 United States dollar | valid 2018-07-01 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_DD06EDC42C13](/claim/clm_DD06EDC42C13.md) | [clm_B831D08FB7D2](/claim/clm_B831D08FB7D2.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040619000053/0000200406-19-000053-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 20,348,000,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_AB6403F31533](/claim/clm_AB6403F31533.md) | [clm_DD06EDC42C13](/claim/clm_DD06EDC42C13.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040618000055/0000200406-18-000055-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 20,021,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_0D67C864AC20](/claim/clm_0D67C864AC20.md) | [clm_AB6403F31533](/claim/clm_AB6403F31533.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040619000033/0000200406-19-000033-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 20,562,000,000 United States dollar | valid 2019-06-30 to 2019-09-29 | conf 0.95 | superseded | superseded_by [clm_3F933BD2AC35](/claim/clm_3F933BD2AC35.md) | [clm_0D67C864AC20](/claim/clm_0D67C864AC20.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040619000053/0000200406-19-000053-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 20,729,000,000 United States dollar | valid 2019-09-29 to 2020-03-29 | conf 0.95 | superseded | superseded_by [clm_B2119111BB6C](/claim/clm_B2119111BB6C.md) | [clm_3F933BD2AC35](/claim/clm_3F933BD2AC35.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040619000066/0000200406-19-000066-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 20,691,000,000 United States dollar | valid 2020-03-29 to 2020-06-28 | conf 0.95 | superseded | superseded_by [clm_2BE2447AD898](/claim/clm_2BE2447AD898.md) | [clm_B2119111BB6C](/claim/clm_B2119111BB6C.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040620000035/0000200406-20-000035-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 18,336,000,000 United States dollar | valid 2020-06-28 to 2020-09-27 | conf 0.95 | superseded | superseded_by [clm_EE9B11ED5636](/claim/clm_EE9B11ED5636.md) | [clm_2BE2447AD898](/claim/clm_2BE2447AD898.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040620000050/0000200406-20-000050-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 21,082,000,000 United States dollar | valid 2020-09-27 to 2021-04-04 | conf 0.95 | superseded | superseded_by [clm_B9399684E5E3](/claim/clm_B9399684E5E3.md) | [clm_EE9B11ED5636](/claim/clm_EE9B11ED5636.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040620000056/0000200406-20-000056-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 22,321,000,000 United States dollar | valid 2021-04-04 to 2021-07-04 | conf 0.95 | superseded | superseded_by [clm_4421AF5C7D38](/claim/clm_4421AF5C7D38.md) | [clm_B9399684E5E3](/claim/clm_B9399684E5E3.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040621000036/0000200406-21-000036-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 23,312,000,000 United States dollar | valid 2021-07-04 to 2021-10-03 | conf 0.95 | superseded | superseded_by [clm_7BE7096E3978](/claim/clm_7BE7096E3978.md) | [clm_4421AF5C7D38](/claim/clm_4421AF5C7D38.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040621000057/0000200406-21-000057-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 23,338,000,000 United States dollar | valid 2021-10-03 to 2022-04-03 | conf 0.95 | superseded | superseded_by [clm_E32E42FD653C](/claim/clm_E32E42FD653C.md) | [clm_7BE7096E3978](/claim/clm_7BE7096E3978.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040621000070/0000200406-21-000070-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 23,426,000,000 United States dollar | valid 2022-04-03 to 2022-07-03 | conf 0.95 | superseded | superseded_by [clm_8AB0CE8C383A](/claim/clm_8AB0CE8C383A.md) | [clm_E32E42FD653C](/claim/clm_E32E42FD653C.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040622000048/0000200406-22-000048-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 24,020,000,000 United States dollar | valid 2022-07-03 to 2022-10-02 | conf 0.95 | superseded | superseded_by [clm_0156A8D2E159](/claim/clm_0156A8D2E159.md) | [clm_8AB0CE8C383A](/claim/clm_8AB0CE8C383A.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040622000071/0000200406-22-000071-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 23,791,000,000 United States dollar | valid 2022-10-02 to 2023-04-02 | conf 0.95 | superseded | superseded_by [clm_76B2CF5C2B3C](/claim/clm_76B2CF5C2B3C.md) | [clm_0156A8D2E159](/claim/clm_0156A8D2E159.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040622000086/0000200406-22-000086-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 24,746,000,000 United States dollar | valid 2023-04-02 to 2023-07-02 | conf 0.95 | superseded | superseded_by [clm_97A678541B72](/claim/clm_97A678541B72.md) | [clm_76B2CF5C2B3C](/claim/clm_76B2CF5C2B3C.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040623000056/0000200406-23-000056-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 25,530,000,000 United States dollar | valid 2023-07-02 to 2023-10-01 | conf 0.95 | superseded | superseded_by [clm_65879BB72EEE](/claim/clm_65879BB72EEE.md) | [clm_97A678541B72](/claim/clm_97A678541B72.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040623000082/0000200406-23-000082-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 21,351,000,000 United States dollar | valid 2023-10-01 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_6B30FD83B744](/claim/clm_6B30FD83B744.md) | [clm_65879BB72EEE](/claim/clm_65879BB72EEE.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040623000102/0000200406-23-000102-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 21,383,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_E210E733741C](/claim/clm_E210E733741C.md) | [clm_6B30FD83B744](/claim/clm_6B30FD83B744.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040624000049/0000200406-24-000049-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 22,447,000,000 United States dollar | valid 2024-06-30 to 2024-09-29 | conf 0.95 | superseded | superseded_by [clm_49A6B41403C2](/claim/clm_49A6B41403C2.md) | [clm_E210E733741C](/claim/clm_E210E733741C.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040624000075/0000200406-24-000075-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 22,471,000,000 United States dollar | valid 2024-09-29 to 2025-03-30 | conf 0.95 | superseded | superseded_by [clm_A0F645CB8D09](/claim/clm_A0F645CB8D09.md) | [clm_49A6B41403C2](/claim/clm_49A6B41403C2.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/0000200406-24-000096-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 21,893,000,000 United States dollar | valid 2025-03-30 to 2025-06-29 | conf 0.95 | superseded | superseded_by [clm_0A1850F0F6B1](/claim/clm_0A1850F0F6B1.md) | [clm_A0F645CB8D09](/claim/clm_A0F645CB8D09.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040625000119/0000200406-25-000119-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 23,743,000,000 United States dollar | valid 2025-06-29 to 2025-09-28 | conf 0.95 | superseded | superseded_by [clm_729D980FE153](/claim/clm_729D980FE153.md) | [clm_0A1850F0F6B1](/claim/clm_0A1850F0F6B1.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/0000200406-25-000178-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 23,993,000,000 United States dollar | valid 2025-09-28 to 2026-03-29 | conf 0.95 | superseded | superseded_by [clm_1D62C3B5C845](/claim/clm_1D62C3B5C845.md) | [clm_729D980FE153](/claim/clm_729D980FE153.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 24,062,000,000 United States dollar | valid 2026-03-29 to 2026-06-28 | conf 0.95 | superseded | superseded_by [clm_0C91EDAB21CE](/claim/clm_0C91EDAB21CE.md) | [clm_1D62C3B5C845](/claim/clm_1D62C3B5C845.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040626000087/0000200406-26-000087-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 25,310,000,000 United States dollar | valid 2026-06-28 to 2026-09-27 | conf 0.95 | superseded | superseded_by [clm_0641FC210206](/claim/clm_0641FC210206.md) | [clm_0C91EDAB21CE](/claim/clm_0C91EDAB21CE.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/0000200406-26-000153-index.htm
- [Johnson & Johnson](/record/johnson-johnson.md) | quarterly_revenue | 25,399,000,000 United States dollar | valid 2026-09-27 to present | conf 0.95 | valid | [clm_0641FC210206](/claim/clm_0641FC210206.md)
  sources: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm

## What replaced what

- $16.48 billion (2012-07-01 to 2012-09-30, [clm_42EF4BA66681](/claim/clm_42EF4BA66681.md)) was replaced by $17.05 billion from 2012-09-30 ([clm_6F9C56DBC614](/claim/clm_6F9C56DBC614.md))
- $17.05 billion (2012-09-30 to 2013-03-31, [clm_6F9C56DBC614](/claim/clm_6F9C56DBC614.md)) was replaced by $17.51 billion from 2013-03-31 ([clm_6F97DEF4B601](/claim/clm_6F97DEF4B601.md))
- $17.51 billion (2013-03-31 to 2013-06-30, [clm_6F97DEF4B601](/claim/clm_6F97DEF4B601.md)) was replaced by $17.88 billion from 2013-06-30 ([clm_7487255D4F9B](/claim/clm_7487255D4F9B.md))
- $17.88 billion (2013-06-30 to 2013-09-29, [clm_7487255D4F9B](/claim/clm_7487255D4F9B.md)) was replaced by $17.58 billion from 2013-09-29 ([clm_F4FECC157EBC](/claim/clm_F4FECC157EBC.md))
- $17.58 billion (2013-09-29 to 2014-03-30, [clm_F4FECC157EBC](/claim/clm_F4FECC157EBC.md)) was replaced by $18.12 billion from 2014-03-30 ([clm_DA690338428C](/claim/clm_DA690338428C.md))
- $18.12 billion (2014-03-30 to 2014-06-29, [clm_DA690338428C](/claim/clm_DA690338428C.md)) was replaced by $19.5 billion from 2014-06-29 ([clm_5CE1ED60A519](/claim/clm_5CE1ED60A519.md))
- $19.5 billion (2014-06-29 to 2014-09-28, [clm_5CE1ED60A519](/claim/clm_5CE1ED60A519.md)) was replaced by $18.47 billion from 2014-09-28 ([clm_EEE18AA71A3F](/claim/clm_EEE18AA71A3F.md))
- $18.47 billion (2014-09-28 to 2017-10-01, [clm_EEE18AA71A3F](/claim/clm_EEE18AA71A3F.md)) was replaced by $19.65 billion from 2017-10-01 ([clm_3D692F025919](/claim/clm_3D692F025919.md))
- $19.65 billion (2017-10-01 to 2018-04-01, [clm_3D692F025919](/claim/clm_3D692F025919.md)) was replaced by $20.01 billion from 2018-04-01 ([clm_74645F257415](/claim/clm_74645F257415.md))
- $20.01 billion (2018-04-01 to 2018-07-01, [clm_74645F257415](/claim/clm_74645F257415.md)) was replaced by $20.83 billion from 2018-07-01 ([clm_B831D08FB7D2](/claim/clm_B831D08FB7D2.md))
- $20.83 billion (2018-07-01 to 2018-09-30, [clm_B831D08FB7D2](/claim/clm_B831D08FB7D2.md)) was replaced by $20.35 billion from 2018-09-30 ([clm_DD06EDC42C13](/claim/clm_DD06EDC42C13.md))
- $20.35 billion (2018-09-30 to 2019-03-31, [clm_DD06EDC42C13](/claim/clm_DD06EDC42C13.md)) was replaced by $20.02 billion from 2019-03-31 ([clm_AB6403F31533](/claim/clm_AB6403F31533.md))
- $20.02 billion (2019-03-31 to 2019-06-30, [clm_AB6403F31533](/claim/clm_AB6403F31533.md)) was replaced by $20.56 billion from 2019-06-30 ([clm_0D67C864AC20](/claim/clm_0D67C864AC20.md))
- $20.56 billion (2019-06-30 to 2019-09-29, [clm_0D67C864AC20](/claim/clm_0D67C864AC20.md)) was replaced by $20.73 billion from 2019-09-29 ([clm_3F933BD2AC35](/claim/clm_3F933BD2AC35.md))
- $20.73 billion (2019-09-29 to 2020-03-29, [clm_3F933BD2AC35](/claim/clm_3F933BD2AC35.md)) was replaced by $20.69 billion from 2020-03-29 ([clm_B2119111BB6C](/claim/clm_B2119111BB6C.md))
- $20.69 billion (2020-03-29 to 2020-06-28, [clm_B2119111BB6C](/claim/clm_B2119111BB6C.md)) was replaced by $18.34 billion from 2020-06-28 ([clm_2BE2447AD898](/claim/clm_2BE2447AD898.md))
- $18.34 billion (2020-06-28 to 2020-09-27, [clm_2BE2447AD898](/claim/clm_2BE2447AD898.md)) was replaced by $21.08 billion from 2020-09-27 ([clm_EE9B11ED5636](/claim/clm_EE9B11ED5636.md))
- $21.08 billion (2020-09-27 to 2021-04-04, [clm_EE9B11ED5636](/claim/clm_EE9B11ED5636.md)) was replaced by $22.32 billion from 2021-04-04 ([clm_B9399684E5E3](/claim/clm_B9399684E5E3.md))
- $22.32 billion (2021-04-04 to 2021-07-04, [clm_B9399684E5E3](/claim/clm_B9399684E5E3.md)) was replaced by $23.31 billion from 2021-07-04 ([clm_4421AF5C7D38](/claim/clm_4421AF5C7D38.md))
- $23.31 billion (2021-07-04 to 2021-10-03, [clm_4421AF5C7D38](/claim/clm_4421AF5C7D38.md)) was replaced by $23.34 billion from 2021-10-03 ([clm_7BE7096E3978](/claim/clm_7BE7096E3978.md))
- $23.34 billion (2021-10-03 to 2022-04-03, [clm_7BE7096E3978](/claim/clm_7BE7096E3978.md)) was replaced by $23.43 billion from 2022-04-03 ([clm_E32E42FD653C](/claim/clm_E32E42FD653C.md))
- $23.43 billion (2022-04-03 to 2022-07-03, [clm_E32E42FD653C](/claim/clm_E32E42FD653C.md)) was replaced by $24.02 billion from 2022-07-03 ([clm_8AB0CE8C383A](/claim/clm_8AB0CE8C383A.md))
- $24.02 billion (2022-07-03 to 2022-10-02, [clm_8AB0CE8C383A](/claim/clm_8AB0CE8C383A.md)) was replaced by $23.79 billion from 2022-10-02 ([clm_0156A8D2E159](/claim/clm_0156A8D2E159.md))
- $23.79 billion (2022-10-02 to 2023-04-02, [clm_0156A8D2E159](/claim/clm_0156A8D2E159.md)) was replaced by $24.75 billion from 2023-04-02 ([clm_76B2CF5C2B3C](/claim/clm_76B2CF5C2B3C.md))
- $24.75 billion (2023-04-02 to 2023-07-02, [clm_76B2CF5C2B3C](/claim/clm_76B2CF5C2B3C.md)) was replaced by $25.53 billion from 2023-07-02 ([clm_97A678541B72](/claim/clm_97A678541B72.md))
- $25.53 billion (2023-07-02 to 2023-10-01, [clm_97A678541B72](/claim/clm_97A678541B72.md)) was replaced by $21.35 billion from 2023-10-01 ([clm_65879BB72EEE](/claim/clm_65879BB72EEE.md))
- $21.35 billion (2023-10-01 to 2024-03-31, [clm_65879BB72EEE](/claim/clm_65879BB72EEE.md)) was replaced by $21.38 billion from 2024-03-31 ([clm_6B30FD83B744](/claim/clm_6B30FD83B744.md))
- $21.38 billion (2024-03-31 to 2024-06-30, [clm_6B30FD83B744](/claim/clm_6B30FD83B744.md)) was replaced by $22.45 billion from 2024-06-30 ([clm_E210E733741C](/claim/clm_E210E733741C.md))
- $22.45 billion (2024-06-30 to 2024-09-29, [clm_E210E733741C](/claim/clm_E210E733741C.md)) was replaced by $22.47 billion from 2024-09-29 ([clm_49A6B41403C2](/claim/clm_49A6B41403C2.md))
- $22.47 billion (2024-09-29 to 2025-03-30, [clm_49A6B41403C2](/claim/clm_49A6B41403C2.md)) was replaced by $21.89 billion from 2025-03-30 ([clm_A0F645CB8D09](/claim/clm_A0F645CB8D09.md))
- $21.89 billion (2025-03-30 to 2025-06-29, [clm_A0F645CB8D09](/claim/clm_A0F645CB8D09.md)) was replaced by $23.74 billion from 2025-06-29 ([clm_0A1850F0F6B1](/claim/clm_0A1850F0F6B1.md))
- $23.74 billion (2025-06-29 to 2025-09-28, [clm_0A1850F0F6B1](/claim/clm_0A1850F0F6B1.md)) was replaced by $23.99 billion from 2025-09-28 ([clm_729D980FE153](/claim/clm_729D980FE153.md))
- $23.99 billion (2025-09-28 to 2026-03-29, [clm_729D980FE153](/claim/clm_729D980FE153.md)) was replaced by $24.06 billion from 2026-03-29 ([clm_1D62C3B5C845](/claim/clm_1D62C3B5C845.md))
- $24.06 billion (2026-03-29 to 2026-06-28, [clm_1D62C3B5C845](/claim/clm_1D62C3B5C845.md)) was replaced by $25.31 billion from 2026-06-28 ([clm_0C91EDAB21CE](/claim/clm_0C91EDAB21CE.md))
- $25.31 billion (2026-06-28 to 2026-09-27, [clm_0C91EDAB21CE](/claim/clm_0C91EDAB21CE.md)) was replaced by $25.4 billion from 2026-09-27 ([clm_0641FC210206](/claim/clm_0641FC210206.md))

## Questions this record answers

### What is Johnson & Johnson's current quarterly revenue?

$25.4 billion, dated September 27, 2026, from a primary source (sec.gov). The record asserts this claim as of November 9, 2026 (status valid, confidence 0.95).

### When did Johnson & Johnson's quarterly revenue last change?

The latest value on the record is $25.4 billion, dated September 27, 2026; before it the record holds $25.31 billion, dated June 28, 2026 and closed on September 27, 2026.

### What was Johnson & Johnson's quarterly revenue before $25.4 billion?

$25.31 billion, valid from June 28, 2026 to September 27, 2026 (status superseded), from a primary source (sec.gov).


## Read on

- This page: /record/johnson-johnson/quarterly_revenue (markdown: /record/johnson-johnson/quarterly_revenue.md)
- Entity twin: /record/johnson-johnson.md · timeline: /timelines/johnson-johnson.md
- Every company's quarterly revenue: /facts/quarterly_revenue.md

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.